---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-022185"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2025-11-13T23:59:59+00:00"
generated_at: "2026-05-16T20:22:19.669715+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "medium"
source: SEC EDGAR
---

# Regen BioPharma issues 23.68M common shares for cash and debt conversion in Oct-Nov 2025

## Summary
- Oct 8, 2025: issued 6.8M shares for $68,000 cash.
- Oct 27, 2025: issued 3.5M shares for $35,000 cash, and 4.5M shares to satisfy $30,204 debt principal plus $13,536 accrued interest.
- Oct 28, 2025: issued 7.1M shares for $71,000 cash.
- Nov 10, 2025: issued 1.78M shares for $17,800 cash under Tier 2 Reg A offering.
- All shares sold directly by management with no underwriter or commission.

## SEC filing metadata
- accession: 0001493152-25-022185
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2025-11-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: medium
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000149315225022185/0001493152-25-022185-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000149315225022185/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-022185
- JSON: https://secwatch.observer/filing/0001493152-25-022185.json
- Plain text: https://secwatch.observer/filing/0001493152-25-022185.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.